Escribano, Baby Boy .

HRN: 25-38-13  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/29/2024
AMPICILLIN 250MG (VIAL)
06/29/2024
07/06/2024
IV
100mg
Q12hours
T/c Neonatal Pneumonia
Waiting Final Action 
06/29/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/29/2024
07/06/2024
IV
27mg
Q24hours
T/c Neonatal Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: